Cofoe Medical Technology (301087.SZ) has set up Hunan Dingxin Kexin Entrepreneurship Investment Fund, which focuses on investing in the medical health and related industries.

Cofoe Medical Technology (301087.SZ) announced that the company has signed a partnership agreement with Hunan Dingxin Taihe Equity Investment Management Co., Ltd. (referred to as "Dingxin Taihe") and Changsha Youhe Metal Materials Co., Ltd. to jointly invest in establishing the Hunan Dingxin Science and Technology New Entrepreneurial Investment Fund Partnership Enterprise (Limited Partnership) (referred to as "Dingxin Science and Technology New"). All partners of Dingxin Science and Technology New have committed a total capital contribution of 45 million yuan, with the company contributing 20 million yuan of its own funds, representing a contribution ratio of 44.44%. Recently, Dingxin Science and Technology New has completed business registration and obtained a business license from the Hunan Xiangjiang New Area Management Committee. It is reported that the investment direction of Dingxin Science and Technology New is in the healthcare and related industries, which aligns with the company's main business direction. This investment will enable the company to fully utilize the resources of all parties, expand into areas relevant and complementary to the company's main business, continuously improve the company's industrial chain, further enhance the company's overall competitiveness and sustainable development capabilities, and promote high-quality development of the company.